Ming Xu

Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial

Lai Wei, Seng Gee Lim, Qing Xie et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 120 citations

Hepatology, Hepatitis C, Viral Hepatitis +6

ELF3 promotes epithelial–mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma

Longbo Zheng, Ming Xu, Junjie Xu et al. · Cell Death and Disease · 2018 · 106 citations · Full text

Attenuation of Luteinizing Hormone Surges in Neuropeptide Y Knockout Mice

Ming Xu, Jennifer W. Hill, Jon E. Levine · Neuroendocrinology · 2000 · 76 citations

Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling

Bo Chen, Ming Xu, Hui Zhang et al. · Biochemical and Biophysical Research Communications · 2013 · 60 citations

Cisplatin-induced Non-apoptotic Death, Pancreatic Cancer, Medicine +10

Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway

Song Chian, Yanna Zhao, Ming Xu et al. · Anti-Cancer Drugs · 2019 · 59 citations

Cisplatin Resistance, Tumor Biology, Health Sciences +15